SG Americas Securities LLC Sells 214,206 Shares of Henry Schein, Inc. $HSIC

SG Americas Securities LLC lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 26.1% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 606,492 shares of the company’s stock after selling 214,206 shares during the quarter. SG Americas Securities LLC’s holdings in Henry Schein were worth $44,698,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HSIC. Artisan Partners Limited Partnership grew its stake in Henry Schein by 5.7% in the third quarter. Artisan Partners Limited Partnership now owns 6,833,041 shares of the company’s stock valued at $453,509,000 after acquiring an additional 370,837 shares during the period. Invesco Ltd. increased its holdings in shares of Henry Schein by 4.1% in the third quarter. Invesco Ltd. now owns 4,731,698 shares of the company’s stock worth $314,043,000 after acquiring an additional 184,763 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Henry Schein by 8.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,816,317 shares of the company’s stock worth $212,865,000 after purchasing an additional 220,149 shares during the period. Ameriprise Financial Inc. lifted its holdings in shares of Henry Schein by 11.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,523,014 shares of the company’s stock valued at $167,453,000 after purchasing an additional 256,156 shares in the last quarter. Finally, Southpoint Capital Advisors LP lifted its holdings in shares of Henry Schein by 38.9% during the 4th quarter. Southpoint Capital Advisors LP now owns 2,500,000 shares of the company’s stock valued at $188,950,000 after purchasing an additional 700,000 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Down 1.6%

Shares of Henry Schein stock opened at $78.67 on Tuesday. The stock has a market cap of $8.96 billion, a P/E ratio of 23.77, a P/E/G ratio of 1.54 and a beta of 0.82. The company has a quick ratio of 0.75, a current ratio of 1.36 and a debt-to-equity ratio of 0.59. Henry Schein, Inc. has a 12-month low of $61.94 and a 12-month high of $89.29. The business’s 50 day moving average is $76.02 and its 200-day moving average is $76.48.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.12. The business had revenue of $3.37 billion during the quarter, compared to analysts’ expectations of $3.34 billion. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the business earned $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts predict that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several research analyst reports. Wall Street Zen lowered Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Sunday, April 26th. Citigroup initiated coverage on shares of Henry Schein in a report on Wednesday, April 15th. They issued a “buy” rating and a $100.00 price objective on the stock. Barrington Research set a $97.00 price objective on shares of Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Leerink Partners restated a “market perform” rating on shares of Henry Schein in a report on Monday, March 9th. Finally, Mizuho lowered their price target on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $87.85.

Insider Buying and Selling

In other news, Director William K. Daniel purchased 10,000 shares of the business’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the completion of the purchase, the director directly owned 20,000 shares in the company, valued at $1,383,800. The trade was a 100.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.89% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.